The British Journal of Psychiatry (2006) 189: 137-143. doi: 10.1192/bjp.bp.105.014308
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hides, L.
Right arrow Articles by Young, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hides, L.
Right arrow Articles by Young, R. M.

Psychotic symptom and cannabis relapse in recent-onset psychosis

Prospective study

L. Hides, PhD (Clin)

School of Applied Psychology, Griffith University, and ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Melbourne

S. Dawe, PhD

School of Applied Psychology, Griffith University, Melbourne

D. J. Kavanagh, PhD

Department of Psychiatry, University of Queensland, Queensland

R. M. Young, PhD

School of Psychology & Counselling, Queensland University of Technology, Queensland, Australia

Correspondence: Dr Leanne Hides, ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Locked Bag 10, Parkville, Melbourne, Victoria Australia, 3052. Tel: +61 3 9342 2800; fax: +61 3 9342 2944; email: lhides{at}unimelb.edu.au

Declaration of interest None.

Funding detailed in Acknowledgements.

Background Cannabis use appears to exacerbate psychotic symptoms and increase risk of psychotic relapse. However, the relative contribution of cannabis use compared with other risk factors is unclear. The influence of psychotic symptoms on cannabis use has received little attention.

Aims To examine the influence of cannabis use on psychotic symptom relapse and the influence of psychotic symptom severity on relapse in cannabis use in the 6 months following hospital admission.

Method At baseline, 84 participants with recent-onset psychosis were assessed and 81 were followed up weekly for 6 months, using telephone and face-to-face interviews.

Results A higher frequency of cannabis use was predictive of psychotic relapse, after controlling for medication adherence, other substance use and duration of untreated psychosis. An increase in psychotic symptoms was predictive of relapse to cannabis use, and medication adherence reduced cannabis relapse risk.

Conclusions The relationship between cannabis use and psychosis may be bidirectional, highlighting the need for early intervention programmes to target cannabis use and psychotic symptom severity in this population.


Related articles in BJP:

Highlights of this issue
Kimberlie Dean
BJP 2006 189: A5. [Full Text]  



This article has been cited by other articles:


Home page
 Schizophr BullHome page
A. Gonzalez-Pinto, S. Alberich, S. Barbeito, M. Gutierrez, P. Vega, B. Ibanez, M. K. Haidar, E. Vieta, and C. Arango
Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
Schizophr Bull, November 13, 2009; (2009) sbp126v1.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
P. Fusar-Poli, J. A. Crippa, S. Bhattacharyya, S. J. Borgwardt, P. Allen, R. Martin-Santos, M. Seal, S. A. Surguladze, C. O'Carrol, Z. Atakan, et al.
Distinct Effects of {Delta}9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Arch Gen Psychiatry, January 1, 2009; 66(1): 95 - 105.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
A. Winstock, T. Lea, and J. Copeland
Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study
J Psychopharmacol, January 1, 2009; 23(1): 84 - 93.
[Abstract] [PDF]

Home page
 Br. J. PsychiatryHome page
S. Zammit, T. H. M. Moore, A. Lingford-Hughes, T. R. E. Barnes, P. B. Jones, M. Burke, and G. Lewis
Effects of cannabis use on outcomes of psychotic disorders: systematic review
The British Journal of Psychiatry, November 1, 2008; 193(5): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
P. Tyrer
From the Editor's desk
The British Journal of Psychiatry, April 1, 2008; 192(4): 320 - 320.
[Full Text] [PDF]